DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Drugs Made In America Acquisition II Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.18−0.00 (-0.05%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Drugs Made In America Acquisition II has not reported a dividend
No dividend per share appears in Drugs Made In America Acquisition II's annual filings since fiscal 2024.